100 related articles for article (PubMed ID: 16435426)
1. New tests for heart disease.
Johns Hopkins Med Lett Health After 50; 2005 Dec; 17(10):4-5. PubMed ID: 16435426
[No Abstract] [Full Text] [Related]
2. Biomarker screening for cardiac dysfunction: the more the merrier?
Tang WH
Am Heart J; 2006 Jul; 152(1):1-3. PubMed ID: 16824825
[No Abstract] [Full Text] [Related]
3. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
Ng LL; Pathik B; Loke IW; Squire IB; Davies JE
Am Heart J; 2006 Jul; 152(1):94-101. PubMed ID: 16824837
[TBL] [Abstract][Full Text] [Related]
4. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.
Sajadieh A; Nielsen OW; Rasmussen V; Ole Hein H; Hansen JF
Pacing Clin Electrophysiol; 2006 Nov; 29(11):1188-94. PubMed ID: 17100670
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase and carbonyl proteins: promising markers for non-invasive monitoring of graft rejection after heart transplantation.
Koestenbauer S; Stiegler P; Stadlbauer V; Mayrhauser U; Leber B; Schweiger M; Wasler A; Prenner G; Sereinigg M; Zelzer S; Stojakovic T; Scarpatetti M; Griesbacher A; Greilberger J; Tscheliessnigg K
J Heart Lung Transplant; 2010 Dec; 29(12):1352-7. PubMed ID: 20591692
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Pradhan AD; Shrivastava S; Cook NR; Rifai N; Creager MA; Ridker PM
Circulation; 2008 Feb; 117(6):823-31. PubMed ID: 18227386
[TBL] [Abstract][Full Text] [Related]
7. Risk marker may play key role in heart disease.
Health News; 2005 Mar; 11(3):2. PubMed ID: 15803566
[No Abstract] [Full Text] [Related]
8. [Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].
Iacoviello L; Donati MB; de Gaetano G
Ital Heart J Suppl; 2001 Sep; 2(9):1031-3. PubMed ID: 11675827
[No Abstract] [Full Text] [Related]
9. Natriuretic peptides find a new home in pulmonology.
Socrates T; Müller C
Respiration; 2009; 77(4):368-9. PubMed ID: 19346742
[No Abstract] [Full Text] [Related]
10. Multiple biomarkers and cardiovascular risk.
Austin MJ; Heneghan MA
N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
[No Abstract] [Full Text] [Related]
11. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Blankenberg S; McQueen MJ; Smieja M; Pogue J; Balion C; Lonn E; Rupprecht HJ; Bickel C; Tiret L; Cambien F; Gerstein H; Münzel T; Yusuf S;
Circulation; 2006 Jul; 114(3):201-8. PubMed ID: 16831981
[TBL] [Abstract][Full Text] [Related]
12. Cardiology patient page. New blood tests for detecting heart disease.
Adams J; Apple F
Circulation; 2004 Jan; 109(3):E12-4. PubMed ID: 14744959
[No Abstract] [Full Text] [Related]
13. Novel risk factors for heart disease. An interview with Gerald Gau, M.D.
Gau G
Mayo Clin Womens Healthsource; 2005 Jun; 9(6):S1-2. PubMed ID: 15888993
[No Abstract] [Full Text] [Related]
14. Questioning the power of C-reactive protein to predict heart disease.
Health News; 2004 May; 10(5):14. PubMed ID: 15132117
[No Abstract] [Full Text] [Related]
15. B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.
Godkar D; Bachu K; Dave B; Niranjan S; Khanna A
Am J Ther; 2008; 15(2):150-6. PubMed ID: 18356635
[TBL] [Abstract][Full Text] [Related]
16. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in acute cardiac disease: the present and the future.
Jaffe AS; Babuin L; Apple FS
J Am Coll Cardiol; 2006 Jul; 48(1):1-11. PubMed ID: 16814641
[TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide: a universal cardiac biomarker?
Teodorovich N; Krakover R; Vered Z
Isr Med Assoc J; 2008 Feb; 10(2):152-3. PubMed ID: 18432033
[No Abstract] [Full Text] [Related]
19. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
20. The promise of expanding the role of BNP testing.
Viljoen A
Int J Clin Pract; 2010 Jan; 64(2):136-8. PubMed ID: 20089003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
